Antiplatelet agents prevent arterial thrombosis by inhibiting platelet aggregation through blocking cyclooxygenase-1, P2Y12 receptors, glycoprotein (GP) IIb/IIIa receptors, or phosphodiesterase pathways. The gene discussed is ART4; the disease is Arterial thrombosis.